Medicine and Dentistry
Head and Neck Cancer
100%
Radiation Therapy
64%
Xerostomia
40%
Parotid Gland
24%
Chemoradiotherapy
23%
Proton Therapy
22%
Neck
20%
Neoplasm
17%
Biological Marker
16%
Intensity Modulated Radiation Therapy
14%
Stem Cell
13%
Plummer-Vinson Syndrome
13%
Quality of Life
10%
Positron Emission Tomography
9%
Salivary Gland
9%
Malignant Neoplasm
9%
Computer Assisted Tomography
9%
Head and Neck Squamous Cell Carcinoma
8%
Submandibular Gland
7%
Acute Toxicity
7%
Frailty
7%
Arm
7%
Plantar Fibromatosis
7%
Sarcopenia
7%
Treatment Planning
6%
Contouring
6%
Positron Emission Tomography-Computed Tomography
6%
Positron Emission Tomography
6%
Randomized Controlled Trial
6%
Tumor Hypoxia
5%
Skeletal Muscle
5%
Overall Survival
5%
Radiomics
5%
Genome Wide Association Study
5%
Cancer Radiotherapy
5%
Fluorodeoxyglucose F 18
5%
Geriatric Assessment
5%
Hypoxia
5%
Single Nucleotide Polymorphism
5%
Side Effect
5%
Nasopharynx Cancer
5%
Keyphrases
Head-and-neck Cancer
42%
Cancer Patients
21%
Radiotherapy
14%
Xerostomia
14%
Normal Tissue Complication Probability Models
9%
Parotid Gland
7%
Sarcopenia
5%
Radiation-induced Xerostomia
5%
Proton Therapy
5%
Digital Biomarkers
5%
Frailty
5%
Stem Cells
5%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
5%
Dysphagia
5%
Patient-rated
5%
Radiation Toxicity
5%
